clinical trial · NCT07468396
A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
Prostate CancerGLR2037
brief summary
A Phase I Clinical Study of GLR2037 in Patients with Advanced Prostate Cancer
started
Apr 30, 2026
primary completion
Oct 30, 2031
completion
Apr 30, 2033
last updated
Mar 12, 2026
official title
A Phase I, Single-arm, Open-label, Multi-center Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GLR2037 in Patients With Metastatic Prostate Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol